Genetic influence on bone turnover in postmenopausal twins

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 140-146

  Garnero, Patrick ^a   Arden, Nigel K ^b   Griffiths, Gareth ^b   Delmas, Pierre D ^a   Spector, Tim D ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; OSTEOCALCIN; PROCOLLAGEN; PYRIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; BONE DEVELOPMENT; BONE RESORPTION; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; TWINS;

EID: 0030023889     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.1.140     Document Type: Article

References (45)

1. Hansen MA, Kirsten O, Riis BJ, Christiansen C. 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study. Br Med J. 303:961-964.
2. Seeman E, Tsalamandris C, Formica C, Hopper JL, McKay J. 1994 Reduced femoral neck bone density in the daughters of women with hip fractures: the role of low peak bone density in the pathogenesis of osteoporosis. J Bone Miner Res. 9:739-743.
3. Moller M, Horsman A, Harvald B, Hauge M, Henningsen K, Nordin BFC. 1978 Metacarpal morphometry in monozygotic and dizygotic twins. Calcif Tissue Int. 25:197-201.
4. Dequeker J, Nijis J, Vertaeten A, Geusen P, Gevers G. 1987. Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone. 8:207-209.
5. Pocock NA, Eisman JA, Hopper J, Yeates M, Sambrook PN, Eberl S. 1987 Genetic determinants of bone mass in adults. J Clin Invest. 80:706-710.
6. Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA. 1991 Genetic factors in bone turnover. J Clin Endocrinol Metab. 72:808-813.
7. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston Jr CC. 1991 Genetic determinants of bone mass in adult women; a reevaluation of the model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res. 6:561-567.
8. Evans RA, Marel GM, Lancaster EK, Kos S, Evans M, Wong SYP. 1988 Bone mass is low in relatives of osteoporotic patients. Ann Intern Med. 109:870-873.
9. Lutz J. 1986 Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs. Am J Clin Nutr. 44:99-106.
10. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. 1992 Contribution of transacting factors alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA. 89:6665-6669.
11. Tokita A, Kelly PJ, Nguyen TV, et al. 1994 Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab. 78:1461-1466.
12. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. 1993 Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res. 8:127-132.
13. Hassager C, Jensen LT, Podenphant J, Thomsen K, Christiansen C. 1994 The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int. 54:30-33.
14. Christiansen C, Rodbro P. 1984 Prediction of rapid bone loss in postmenopausal women. Lancet. 1:1105-1108.
15. Christian JC, Yu PL, Slemenda CW, Johnston Jr CC. 1989 Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet. 44:429-433.
16. Kelly PJ, Nguyen T, Hopper J, Pocock N, Sambrook P, Eisman J. 1993 Changes in axial bone density with age: a twin study. J Bone Miner Res. 8:11-17.
17. Slemenda C, Hui SL, Longcope C, Johnston CC 1987 Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest. 80: 1261-1269.
18. Johansen J, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest. 18:191-195.
19. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab. 72:367-373.
20. Delmas PD. 1993 Biochemical markers of bone turnover. J Bone Miner Res. 8(Suppl 2):S549-S554.
21. Garnero P, Delmas PD. 1993 Assessment of the serum levels of bone aklaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 77:1046-1053.
22. Garnero P, Grimaux M, Demiaux B, Préaudat C, Seguin P, Delmas PD. 1992 Measurement of serum osteocalcin with a human-specific two-site radioimmunoassay. J Bone Miner Res. 7:1389-1397.
23. Eyre DR, Koob TJ, Van Neww KP. 1984 Quantitation of hydroxypyridinium cross links in collagen by high performance liquid chromatography. Anal Biochem. 137:380-388.
24. Black D, Buncan A, Robins SP. 1989 Quantitative analysis of pyridinium cross links of collagen in urine using ion-paired reversed-phase high performance chromatography. Anal Biochem. 169:197-203.
25. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. 1990 Urinary excretion of pyridinium cross links: a new marker of bone resorption in metabolic bone disease. Bone Miner. 8:87-96.
26. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. 1991 Evaluation of urinary hydroxypyridinium cross link measurements as resorption markers in metabolic bone disease. Eur J Clin Invest. 21:310-315.
27. Seyedin SM, Kung VT, Daniloff YN, et al. 1993 Immunoassay for urinary pyridinoline. The new marker of bone resorption. J Bone Miner Res. 8:635-641.
28. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. 1994 Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res. 9:1643-1649.
29. Hanson DA, Weis MAE, Bollen AM, Maslan SH, Singer FR, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type 1 collagen cross linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
30. Garnero P, Gineyts E, Riou JP, Delmas PD. 1994 Assessment of bone resorption with 3 new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab. 79:780-785.
31. Garnero P, Grimaux M, Seguin P, Delmas PD. 1994 Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res. 9:255-264.
32. Winterbottom N, Vernon S, Freeman K, Daniloff G, Seyedin S. 1993 A serum immunoassay for the C-terminal propeptide of type I collagen. J Bone Miner Res. 8(Suppl 1):S341.
33. Williams CJ, Christian JC, Norton JA. 1992 Twinan 90: a FORTRAN program for conducting ANOVA based and likelihood based analysis of twin data. Comp Methods Progr Biomed. 38:167-176.
34. Morrison NA, Qi JC, Tokita A, et al. 1994 Prediction of bone density from vitamin D receptor alleles. Nature (Lond). 367:284-287.
35. Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J. 1994 Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest. 94:2130-2134.
36. Garnero P, Borel O, Somay-Rendu E, Delmas PD. Vitamin D receptor gene alleles do no predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res. 10:1283-1288.
37. Spector TD, Keen RW, Arden NK, et al. 1995 Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. Br Med J. 310:1357-1360.
38. Keen RW, Major PJ, Lanchbury JS, Spector TD. 1995 Vitamin D receptor gene polymorphism and bone loss. Lancet. 345:990.
39. Eastell R, Delmas PD, Hodgson SF, Ericksen EF, Mann KG, Riggs BL. 1988 Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers. J Clin Endocrinol Metab. 67:741-748.
40. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. 1984 Serum bone gla protein: a sensitive marker for bone turnover in postmenopausal osteoporosis. Lancet. 1:1091-1093.
41. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL. 1983 Increase in serum bone gamma carboxyglutamic acid protein with aging in women. J Clin Invest. 71:1316-1421.
42. Parfitt AM, Simon S, Villanueva AR, Krane SM. 1987 Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen synthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res. 2:427-436.
43. Garnero P, Shih W, Gineyts E, Karpf DB, Delmas PD. 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 79:1693-1700.
44. Hassager C, Fabbri-Mabelli G, Christiansen C. 1993 The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen. Osteoporosis Int. 3:50-52.
45. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. 1995 Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone crosslinks excretion. J Bone Miner Res. 10:647-649.